INDIA APPROVES MEDICAL SMARTWATCHES: Is This the Next Billion-Dollar Health Tech Revolution?

HEALTHCAREBIOTECH
Whalesbook Logo
AuthorAnanya Iyer|Published at:
INDIA APPROVES MEDICAL SMARTWATCHES: Is This the Next Billion-Dollar Health Tech Revolution?
Overview

Smartwatches are transitioning into certified medical devices in India, with features like hypertension and ECG monitoring gaining government approval. While overall smartwatch sales are down, the medical wearable market, including smartwatches, is poised for significant growth, projected to reach $4.2 billion by 2033. Companies like Apple and Samsung are leading this shift, attracting startups and creating a burgeoning health tech opportunity.

The Shift to Clinical Grade

Smartwatches are rapidly evolving from mere lifestyle accessories into certified medical devices in India. Recent government approvals are paving the way for devices that can monitor critical health parameters, signaling a major shift in the consumer electronics landscape. This transition is driven by the need for differentiation in a declining smartwatch market and a burgeoning opportunity in health technology.

The Central Drugs Standard Control Organisation (CDSCO) is now granting approvals for advanced health features on smartwatches. Apple recently secured clearance for hypertension-related tracking on its latest Apple Watch Series 11, a feature that monitors blood oxygen, stress, and heart parameters. This follows Samsung's earlier introduction of blood pressure and electrocardiogram (ECG) capabilities in its Galaxy Watch 6 series, which also received CDSCO certification. These clinical-grade features distinguish premium devices from basic trackers.

Market Dynamics

The overall smartwatch market in India has seen a decline, with sales falling 34% in 2024 and 28% year-on-year in the first half of this year. However, the medical wearable market, including smartwatches with health functionalities, is experiencing explosive growth. Market research group Imarc projects India's wearable healthcare market to expand from its current $1.04 billion valuation to $4.2 billion by 2033. India currently holds 2.5% of the global wearable healthcare market, indicating substantial room for expansion.

Key Players and Differentiation

Companies like Apple and Samsung are increasingly relying on sophisticated medical tracking to attract consumers in the premium segment. Tarun Pathak, research director at Counterpoint India, notes that specialized features requiring expensive clinical trials are the "only real avenue to differentiate smartwatches in the premium segment." This strategy aims to enhance appeal and adoption higher up the consumer value chain. Other players like Garmin and Huawei are also entering this space with similar advanced features, although their CDSCO certification status is less clear.

Startup Innovation

This trend is also spurring innovation among Indian startups. Bengaluru-based Ultrahuman, which offers a continuous glucose monitor, raised $12 million to expand its operations. Gurugram-based Gabit introduced a wearable ring with advanced health monitoring features. While these startups are developing novel solutions, widespread adoption in India's billion-dollar wearable healthcare industry is still largely dominated by clinical monitors used in hospitals by companies like Philips, Nikon, and Abbott.

Expert Analysis

Medical practitioners see significant potential in these advanced health features. Dr Amitabha Bhattacharya, an Indian Medical Association representative, believes that clinical-grade tracking in mainstream smartwatches can enable proactive diagnosis of hard-to-detect conditions and provide vital guidance for regular health tracking, especially for patients at risk of chronic ailments.

Impact

The growing integration of medical-grade features into consumer smartwatches is expected to drive innovation, create new investment opportunities in the health-tech sector, and potentially improve public health outcomes through earlier disease detection and management. This trend signifies a substantial shift towards preventative healthcare enabled by accessible technology.

Impact Rating: 8/10

Difficult Terms Explained

Hypertension is a medical condition characterized by persistently elevated blood pressure, which can damage heart tissues over time. ECG, or Electrocardiogram, is a test that records the electrical activity of the heart, used to detect heart problems. CDSCO, the Central Drugs Standard Control Organisation, is India's statutory body responsible for the regulation of pharmaceuticals and medical devices, ensuring quality and safety. Blood Oxygen refers to the amount of oxygen carried in the blood, often monitored by wearables to assess respiratory and circulatory health. A Continuous Glucose Monitor (CGM) is a device that tracks glucose levels in the body continuously, typically used by individuals with diabetes. Heart Rate Variability (HRV) is the variation in time between heartbeats, used as an indicator of stress and recovery.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.